1. FRI0488 Analysis of REAL Life Vasoactive Therapy in over 3000 Patients with Systemic Sclerosis (SSC) Reveals Considerable Undertreatment and Significant Changes of Treatment Practice since 2004. (10th June 2014) Authors: Moinzadeh, P.; Elisabeth, A.; Blank, N.; Distler, J.; Fierlbeck, G.; Genth, E.; Guenther, C.; Hein, R.; Henes, J.; Hellmich, M.; Herrgott, I.; Koetter, I.; Kreuter, A.; Krieg, T.; Melchers, I.; Mensing, H.; Mueller-Ladner, U.; Pfeiffer, C.; Riemekasten, G.; Sárdy, M. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0209 The Risk for Initial Digital Ulcer Involvement in SSC Patients Decreases with Disease Duration Since the Beginning of Raynaud Phenomenon. (23rd January 2014) Authors: Moinzadeh, P.; Hunzelmann, N.; Mueller-Ladner, U.; Meier, F.; Riemekasten, G.; Becker, M.; Kreuter, A.; Wozel, G.; Melchers, I.; Sardy, M.; Herrgott, I.; Graefenstein, K.; Fierlbeck, G.; Pfeiffer, C.; Worm, M.; Burkhardt, H.; Mensing, H.; Kuhr, K.; Sunderkoetter, C.; Krieg, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase‐1 antibodies. (1st June 2016) Authors: Hunzelmann, N.; Riemekasten, G.; Becker, M.O.; Moinzadeh, P.; Kreuter, A.; Melchers, I.; Mueller‐Ladner, U.; Meier, F.; Worm, M.; Lee, H.; Herrgott, I.; Pfeiffer, C.; Fierlbeck, G.; Henes, J.; Juche, A.; Zeidler, G.; Mensing, H.; Günther, C.; Sárdy, M.; Burkhardt, H. Journal: British journal of dermatology Issue: Volume 174:Number 6(2016) Page Start: 1384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase‐1 antibodies. (20th March 2016) Authors: Hunzelmann, N.; Riemekasten, G.; Becker, M.O.; Moinzadeh, P.; Kreuter, A.; Melchers, I.; Mueller‐Ladner, U.; Meier, F.; Worm, M.; Lee, H.; Herrgott, I.; Pfeiffer, C.; Fierlbeck, G.; Henes, J.; Juche, A.; Zeidler, G.; Mensing, H.; Günther, C.; Sárdy, M.; Burkhardt, H. Journal: British journal of dermatology Issue: Volume 174:Number 6(2016) Page Start: 1384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗